These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8636319)

  • 1. Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma.
    Schuval BJ; Kirschenbaum A; Wolfe D; Post KD; Levine AC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):864. PubMed ID: 8636319
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
    Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
    J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
    Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
    Int J Urol; 2006 Jan; 13(1):87-8. PubMed ID: 16448441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
    Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
    Int J Urol; 2006 Mar; 13(3):303-4. PubMed ID: 16643633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma.
    Ogan K; Berger M; Ball R
    J Urol; 1998 Aug; 160(2):497-8. PubMed ID: 9679910
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
    Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
    J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
    Hernandez Morin N; Huet D; Hautecouverture M
    Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary apoplexy after leuprolide.
    Davis A; Goel S; Picolos M; Wang M; Lavis V
    Pituitary; 2006; 9(3):263-5. PubMed ID: 16832587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotroph adenomas.
    Samuels MH
    Curr Ther Endocrinol Metab; 1994; 5():52-6. PubMed ID: 7704786
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.
    Guerra Y; Lacuesta E; Marquez F; Raksin PB; Utset M; Fogelfeld L
    Pituitary; 2010; 13(1):54-9. PubMed ID: 19842040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
    Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
    J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotroph-cell pituitary adenomas.
    Molitch ME
    N Engl J Med; 1991 Feb; 324(9):626-7. PubMed ID: 1899471
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gonadotroph adenomas].
    Takada K; Yamada S; Teramoto A
    Nihon Rinsho; 1993 Oct; 51(10):2691-5. PubMed ID: 8254941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FSH-producing hypophyseal tumor in a 13-year-old girl].
    Etzrodt A; Etzrodt H; Hey O
    Geburtshilfe Frauenheilkd; 1990 Jan; 50(1):73-5. PubMed ID: 2107120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersecretion of LH and FSH by a pituitary adenoma.
    Snyder PJ; Sterling FH
    J Clin Endocrinol Metab; 1976 Mar; 42(3):544-50. PubMed ID: 767353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gonadotroph Pituitary Adenoma Causing Severe Headache Following Repeated Use of GnRH Agonist for Prostate Cancer].
    Shimada H; Sasaki H; Kasai K; Egawa S
    Hinyokika Kiyo; 2019 May; 65(5):171-174. PubMed ID: 31247696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gonadotroph pituitary adenomas].
    Chanson P
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.
    Lawrentschuk N; Fernandes K; Bell D; Barkin J; Fleshner N
    J Urol; 2011 Mar; 185(3):848-54. PubMed ID: 21239017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.
    Djerassi A; Coutifaris C; West VA; Asa SL; Kapoor SC; Pavlou SN; Snyder PJ
    J Clin Endocrinol Metab; 1995 Feb; 80(2):591-4. PubMed ID: 7852525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.